Publicaciones en colaboración con investigadores/as de Centro Nacional de Investigaciones Oncológicas (4)

2022

  1. Exploiting 4-1BB immune checkpoint to enhance the efficacy of oncolytic virotherapy for diffuse intrinsic pontine gliomas

    JCI Insight, Vol. 7, Núm. 7

2015

  1. Activated and expanded natural killer cells target osteosarcoma tumor initiating cells in an NKG2D-NKG2DL dependent manner

    Cancer Letters, Vol. 368, Núm. 1, pp. 54-63

2011

  1. Effect of ABCB1 and ABCC3 polymorphisms on osteosarcoma survival after chemotherapy: A pharmacogenetic study

    PLoS ONE, Vol. 6, Núm. 10

2009

  1. Common variations in ERCC2 are associated with response to cisplatin chemotherapy and clinical outcome in osteosarcoma patients

    Pharmacogenomics Journal, Vol. 9, Núm. 5, pp. 347-353